Market Overview:
The global docetaxel trihydrate API market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for oncology drugs, and growing focus on R&D activities by pharmaceutical companies. Based on type, the global docetaxel trihydrate API market is segmented into purity ≥ 98 % and purity ≥ 99 %. The purity ≥ 98 % segment is expected to account for a larger share of the market in 2018. This can be attributed to the higher demand for drugs with high levels of purity. Based on application, the global docetaxel trihydrate API market is segmented into docetaxel trihydrate injection and other applications.
Product Definition:
Docetaxel Trihydrate API is a white to off-white crystalline powder with a molecular formula of C43H53NO14•3H2O and a molecular weight of 882.97. It is slightly soluble in water, but more soluble in ethanol and methanol. The product is used as an anticancer agent.
Purity ≥ 98 %:
Docetaxel Trihydrate is a pure taxane-based drug, which is manufactured by the reaction of dihydro Docetaxel with triethylamine. It has been reported that Docetaxel Trihydrate API has an efficacy similar to that of conventional Taxotere (Taxol) in terms of growth inhibition in various cancer cell lines including breast, lung, and prostate carcinoma cell lines.
Purity ≥ 99 %:
Docetaxel Trihydrate is a pure taxane-based API developed by the collaboration of Dr. Reddy's Laboratories and Wockhardt Limited. Docetaxel trihydrate has been reported to have 99% purity as per the analysis done by GFC (Government Food & Drug Analysis) laboratory, which is certified by WHO and FDA.
Application Insights:
Docetaxel trihydrate injection was the dominant application segment in the global docetaxel API market and accounted for a revenue share of over 60.0% in 2017. This is due to its wide usage as a chemotherapeutic agent for the treatment of advanced breast cancer, non-small cell lung cancer, and other cancers.
The other applications include taxanes such as paclitaxel andTaxol; these are used for various indications including ovarian carcinoma, testicular tumorigenesis & spermatogenesis research; osteosarcoma; brain tumor therapy preclinical testing; and others.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of major manufacturers such as Pfizer, Inc.; F. Hoffmann-La Roche AG; and AbbVie, Inc. In addition, these players are involved in extensive R&D activities for developing novel formulations that meet the healthcare needs of patients.
Asia Pacific is expected to witness lucrative CAGR during the forecast period due to rising healthcare expenditure by governments along with an increase in income levels among people is anticipated to boost demand for advanced treatment options like docetaxel trihydrate API.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the docetaxel trihydrate API market. According to a study by World Health Organization (WHO), it is estimated that around 14 million new cases of cancer were diagnosed in 2012 and this number is expected to rise to 24 million by 2035. This will create a high demand for docetaxel trihydrate API, as it is one of the most commonly used drugs for treating various types of cancers.
- Rising awareness about cancer treatments: There has been a rising awareness about different types of cancers and their treatments in recent years. This has led to an increase in the demand for docetaxel trihydrate API, as it is one of the most effective drugs available for treating various forms of cancer.
- Technological advancements in chemotherapy: The technological advancements in chemotherapy are another major growth driver for the docetaxel trihydrate API market. With continuous innovations taking place in this field, more effective and safer chemotherapeutic agents are being developed every day, which is driving up demand for docetaxel trihydrate API globally .
Scope Of The Report
Report Attributes
Report Details
Report Title
Docetaxel Trihydrate API Market Research Report
By Type
Purity ≥ 98 %, Purity ≥ 99 %
By Application
Docetaxel Trihydrate Injection, Other
By Companies
Arca Pharmalabs, Cipla, Scion Pharm Taiwan, Fresenius Kabi Oncology, Chem Genix, Qilu Pharmaceutial, Polymed Therapeutics, Zhejiang Hisun Pharmaceutical, Sai Phytoceuticals, Berr Chemical, Arca Pharmalabs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Docetaxel Trihydrate API Market Report Segments:
The global Docetaxel Trihydrate API market is segmented on the basis of:
Types
Purity ≥ 98 %, Purity ≥ 99 %
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Docetaxel Trihydrate Injection, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Arca Pharmalabs
- Cipla
- Scion Pharm Taiwan
- Fresenius Kabi Oncology
- Chem Genix
- Qilu Pharmaceutial
- Polymed Therapeutics
- Zhejiang Hisun Pharmaceutical
- Sai Phytoceuticals
- Berr Chemical
- Arca Pharmalabs
Highlights of The Docetaxel Trihydrate API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity ≥ 98 %
- Purity ≥ 99 %
- By Application:
- Docetaxel Trihydrate Injection
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Docetaxel Trihydrate API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Docetaxel Trihydrate API is a powder form of docetaxel that is used to treat cancer. It is a chemotherapy drug that works by killing cancer cells.
Some of the major companies in the docetaxel trihydrate api market are Arca Pharmalabs, Cipla, Scion Pharm Taiwan, Fresenius Kabi Oncology, Chem Genix, Qilu Pharmaceutial, Polymed Therapeutics, Zhejiang Hisun Pharmaceutical, Sai Phytoceuticals, Berr Chemical, Arca Pharmalabs.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Docetaxel Trihydrate API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Docetaxel Trihydrate API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Docetaxel Trihydrate API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Docetaxel Trihydrate API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Docetaxel Trihydrate API Market Size & Forecast, 2018-2028
4.5.1 Docetaxel Trihydrate API Market Size and Y-o-Y Growth
4.5.2 Docetaxel Trihydrate API Market Absolute $ Opportunity
Chapter 5 Global Docetaxel Trihydrate API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Docetaxel Trihydrate API Market Size Forecast by Type
5.2.1 Purity ≥ 98 %
5.2.2 Purity ≥ 99 %
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Docetaxel Trihydrate API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Docetaxel Trihydrate API Market Size Forecast by Applications
6.2.1 Docetaxel Trihydrate Injection
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Docetaxel Trihydrate API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Docetaxel Trihydrate API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Docetaxel Trihydrate API Analysis and Forecast
9.1 Introduction
9.2 North America Docetaxel Trihydrate API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Docetaxel Trihydrate API Market Size Forecast by Type
9.6.1 Purity ≥ 98 %
9.6.2 Purity ≥ 99 %
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Docetaxel Trihydrate API Market Size Forecast by Applications
9.10.1 Docetaxel Trihydrate Injection
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Docetaxel Trihydrate API Analysis and Forecast
10.1 Introduction
10.2 Europe Docetaxel Trihydrate API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Docetaxel Trihydrate API Market Size Forecast by Type
10.6.1 Purity ≥ 98 %
10.6.2 Purity ≥ 99 %
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Docetaxel Trihydrate API Market Size Forecast by Applications
10.10.1 Docetaxel Trihydrate Injection
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Docetaxel Trihydrate API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Docetaxel Trihydrate API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Docetaxel Trihydrate API Market Size Forecast by Type
11.6.1 Purity ≥ 98 %
11.6.2 Purity ≥ 99 %
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Docetaxel Trihydrate API Market Size Forecast by Applications
11.10.1 Docetaxel Trihydrate Injection
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Docetaxel Trihydrate API Analysis and Forecast
12.1 Introduction
12.2 Latin America Docetaxel Trihydrate API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Docetaxel Trihydrate API Market Size Forecast by Type
12.6.1 Purity ≥ 98 %
12.6.2 Purity ≥ 99 %
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Docetaxel Trihydrate API Market Size Forecast by Applications
12.10.1 Docetaxel Trihydrate Injection
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Docetaxel Trihydrate API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Docetaxel Trihydrate API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Docetaxel Trihydrate API Market Size Forecast by Type
13.6.1 Purity ≥ 98 %
13.6.2 Purity ≥ 99 %
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Docetaxel Trihydrate API Market Size Forecast by Applications
13.10.1 Docetaxel Trihydrate Injection
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Docetaxel Trihydrate API Market: Competitive Dashboard
14.2 Global Docetaxel Trihydrate API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Arca Pharmalabs
14.3.2 Cipla
14.3.3 Scion Pharm Taiwan
14.3.4 Fresenius Kabi Oncology
14.3.5 Chem Genix
14.3.6 Qilu Pharmaceutial
14.3.7 Polymed Therapeutics
14.3.8 Zhejiang Hisun Pharmaceutical
14.3.9 Sai Phytoceuticals
14.3.10 Berr Chemical
14.3.11 Arca Pharmalabs
